Company:  ALBANY MOLECULAR RESEARCH ... (AMRI)
Form Type:  10-Q
Filing Date:  8/9/2012 
CIK:  0001065087 
Address:  21 CORPORATE CIRCLE
P O BOX 15098
 
City, State, Zip:  ALBANY, New York 12203-5154 
Telephone:  (518) 464-0279 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$16.44  
Change: 
-0.18 (-1.08%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$531.46M
Description of Business
Albany Molecular Research, Inc. is a leading global contract research and manufacturing organization providing customers fully integrated drug discovery, development, and manufacturing services. We supply a broad range of services and technologies supporting the discovery and development of pharmaceutical products, the manufacturing of Active Pharmaceutical Ingredients (�API�) and the manufacturing of drug product for existing and experimental new drugs, as well as research, development and manufacturing for the agrochemical and other industries. With locations in the United States, Europe, and Asia, AMRI maintains geographic proximity to our customers and flexible cost models. AMRI has also historically leveraged its drug-discovery expertise to execute on several internal drug discovery programs, certain of which have been successfully partnered.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      Item 1. Condensed Consolidated Financial Statements (Unaudited)
        INCOME STATEMENT
        BALANCE SHEET
        CASH FLOW
        Note 1 - Summary of Operations and Significant Accounting ...
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures about ...
      Item 4. Controls and Procedures
    PART II - OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION
  EXHIBIT 32.2
    CERTIFICATION
BROKERAGE PARTNERS